TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nauclér Medical AB
Closing information (x1000 EUR)
Closing information | 2024/12 | 2023/12 | 2022/12 |
Turnover |
17
![]() |
17 | |
Financial expenses |
0
![]() |
0 | |
Earnings before taxes |
10
|
11 | |
EBITDA |
10
|
11 | |
Total assets |
13
|
14 | |
Current assets |
13
|
14 | |
Current liabilities |
3
![]() |
3 | |
Equity capital |
10
|
11 | |
- share capital |
2
![]() |
2 | |
Employees (average) |
1
|
0
![]() |
0 |
Financial ratios
Fiscal year | 2024/12 | 2023/12 | 2022/12 |
Solvency |
76.9%
|
78.6% | |
Turnover per employee | |||
Profit as a percentage of turnover |
58.8%
|
64.7% | |
Return on assets (ROA) |
76.9%
|
78.6% | |
Current ratio |
433.3%
|
466.7% | |
Return on equity (ROE) |
100%
![]() |
100% | |
Change turnover |
0
|
-7 | |
Change turnover % |
-32%
|
0%
|
-28% |
Chg. No. of employees |
1
|
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2024/12 | 2023/12 | 2022/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.